good news: adar poonawalla after 16 european nations recognise covishield
Published 3 years ago • 446 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:17
good news for travellers that covishield recognised by 16 european nations : sii's adar poonawalla
-
2:18
covid-19: 16 european countries recognise covishield| adar poonawalla hails good news| oneindia news
-
0:16
serum institute ceo, adar poonawalla receives covid-19 vaccine i mojo story
-
3:31
adar poonawalla terms vaccine 'covishield' dispatch as 'historic moment'
-
1:19
good news on vaccine soon: adar poonawalla
-
37:37
time to unlock coronavirus vaccination in india? ceo of sii adar poonawalla exclusive | newstrack
-
24:11
serum institute’s journey to success | adar poonawalla to et now
-
3:30
india sees rise in demand for gold
-
1:35
"india has no further orders for covishield"- adar poonawalla, serum institute ceo
-
2:03
"discussed vaccine implementation plan with pm modi": adar poonawalla
-
0:45
covishield-maker adar poonawalla to meet union health minister today | breaking news
-
1:41
covid-19 news | "hope to resolve soon": adar poonawalla on covishield vaccine, eu travel issues
-
3:13
vaccine shortage may continue till july,' says serum ceo adar poonawalla
-
0:58
covid-19 news: adar poonawalla's serum institute to invest 240 million pounds in uk
-
2:01
covishield prices for states reduced to rs 300 per dose, says adar poonawalla | breaking news
-
8:21
adar poonawalla speaks on the journey of producing coronavirus vaccine | exclusive
-
7:42
newsmakers 2021: meet the vaccine king of india- adar poonawalla | exclusive
-
24:46
when covid vaccine will be ready? answers serum institute's ceo adar poonawalla | news unlocked
-
4:55
india's covid-19 vaccine shortage will continue till july: serum institute's adar poonawalla
-
5:55
adar poonawalla opens up about covishield's comparison with other vaccines like moderna & pfizer
-
0:48
adar poonawalla on top 3 developments in vaccine world | ndtv exclusive
-
24:07
adar poonawalla, ceo of world's biggest vaccine maker, reveals post-covid expansion plans